tiletamine hydrochloride has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TC; Lee, SY; Li, YF; Lin, PH; Tu, QW; Yen, IC | 1 |
1 other study(ies) available for tiletamine hydrochloride and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation.
Topics: 4-Butyrolactone; Animals; Cyclohexanones; Endoplasmic Reticulum Stress; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RAW 264.7 Cells; Receptors, Cell Surface | 2021 |